2020

BI PHARMA

J B ELAMFebruary 4-6, 2020 February 7, 2020

Institute of Chemical TechnologyMatunga, Mumbai

Presents

February 8, 2020

3 2

2020

BI PHARMA

J B ELAM

INDEX

AGENDA ....................................................................................................... 3-7

GOLD SPONSOR AND EXHIBITOR ............................................................. 8

BRONZE SPONSORS AND EXHIBITORS..................................................... 9-12

PARTNER ...................................................................................................... 13

COLLABORATORS & EXHIBITORS. ............................................................. 14-15

EXHIBITORS ................................................................................................. 16-19

BIOPHARMA JOBMELA SUPPOTERS ........................................................ 20

3 2

2020

BI PHARMA

J B ELAM

TIME ACTIVITY SPEAKERS VENUE

4th February 2020: Biopharma Exhibition01:15 pm – 01:45 pm Inaugration of Biopharma Exhibition & Welcome

address by Chief GuestDr. Satyanarayana S, PhD, Head Quality Control, Dr. Reddy

Pidilite Pavilion

01:45 pm Onwards Lunch & Exhibtion open to All Visitors 04:00 pm – 04:30 pm Tea Break04:30 pm – 06:30 pm Marketing Activities by Visitors 06:30 pm – 6:50 pm Technology Showcase by Agilent Parul Thakur06:50 pm – 07:10 pm Technology Showcase by Biotechne Mr. Manish Singh07:10 pm Onwards Dinner and Networking09:00 pm Closing for the day 1

5th February 2020: Biopharma Exhibition10:00 am Exhibition open to all Visitors

Pidilite Pavilion01:30 pm Lunch & Networking02:30 pm Marketing and Interaction05:30 pm Inaugration of Mass Spec and Lab Visit Mass Spectometry

Lab06:00 pm Lecture About the Facility and Its Vision Dr. Ratnesh Jain

Pidilite Pavilion06:15 pm Lecture on Advance Mass Spectrometry W. TinHua07:00 pm Discussion and Networking07:30 pm Onwards Dinner09:00 pm Closing for Day 2

Ag

end

a

5 4

2020

BI PHARMA

J B ELAM

TIME ACTIVITY SPEAKERS VENUE

6th February 2020: Biopharma Exhibition10:00 am Exhibition Open to all Visitors

Pidilite Pavilion

01:30 pm Lunch & NetworkingAfter Lunch Exhibition Closing07:00 pm – 7:20 pm Technology Showcase by Malvern Stuart Wakefield07:30 pm Onwards Dinner & Networking09:00 pm Closing for Day 3

7th February 2020: Biopharma Job Mela02:00 pm – 02:30 pm Inaugration of Job Mela & Welcome Talk Dr. Meenakshi Munshi,

DBT Govt India

Pidilite Pavilion

02:30 pm – 02:50 pm Employment Opportunities and Work Culture: Biocon HR Team 02:50 pm – 03:10 pm Employment Opportunities and Work Culture: Biocon HR Team 03:10 pm – 03:50 pm Employment Opportunities and Work Culture: Syngene HR Team 03:30 pm – 03:45 pm Q&A03:45 pm – 04:30 pm CII Initiative for Higher Education by Industry-Institute

Partnership Neha Gupta

04:30 pm – 05:15 pm Informal Panel Interaction with Leaders and students: Career Showcase

Shreehas Tambe (Biocon), Dhanan-jay Patankar (Syngene), Prof. Tatu (IISC), Sandeep Majumdar (INTAS) Kavitha Iyer Rodrigues (Zumutor)

05:15 pm Onwards Refreshment & Networking

Ag

end

a

5 4

2020

BI PHARMA

J B ELAMA

gend

a Time Activities

09:00 am – 09:30 am Registration and refreshments

09:30 am – 09:40 am Welcome address by VC Prof. AB Pandit

09.40 am – 09.45 am Expectation from the Conclave: Ratnesh Jain

09.45 am – 09.50 am Guiding Talk: Prof. MM Sharma

09.50 am – 10.00 am Book Launch: Intracellular Drug Delivery

10:00 am – 10:05 am Introdcution of Speaker: Prof. AB Pandit

10:05 am – 10.45 am Keynote Talk: Mrs. Kiran Mazumdar Shaw, CMD, Biocon Limited

10.45 am – 10.55 am Q&A

10.55 am – 11.00 am Vote of Thanks: Prajakta Dandekar Jain

11.00 am – 11.30 am Tea, Networking and Innovation of ICT (Exhibition)

2020

7 6

2020

BI PHARMA

J B ELAMA

gend

a

Time Activities Speakers/Panelists

Session A: Global Policy and Engagement with Indian Biopharmaceutical Industry

Moderator: Dr. Dhananjay Patankar, Vice President, Syngene

11:30 am – 12:30 pm Panel Discussion 1) Dr. Cyrus Karkaria, President, Biotech Dep., Lupin 2) Dr. Ayesha Sitlani, Associate VP, IAVI 3) Ms. Kavitha Iyer Rodrigues, CEO, Zumutor4) Dr. Kevin Carrick, Director, USP-RKV 5) Dr. Amita Goel, CEO, Celltheon

12:30 pm – 01:00 pm Talk Session Dr. Ayesha Sitlani, Associate VP, IAVI

01:00 pm – 02:00 pm Lunch

Session B: Indian Policy (Health, Insurance and Make in India)

Moderator: Mr. Vikas Dandekar, Editor, Economic Times

02:00 pm – 03:00 pm Panel Discussion 1) Dr Ajai Agarwal, GM, HN & QA, Ayushman Bharat2) Dr. Rajat Goyal, Country Director, IAVI 3) Mr. Mahesh Balasubramanian, MD&CEO, Kotak GI4) Dr. Kavita Singh, Director, NBM, BIRAC 5) Dr. Alka Sharma, Scientist ‘G’, DBT

7 6

2020

BI PHARMA

J B ELAM

Time Activities Speakers/PanelistsSession C: Biomanufacturing, Technology, Services and Innovations

Moderator: Prof. Anurag Rathore, IIT Delhi03:00 pm – 04:00 pm Panel Discussion 1) Dr. Sachin Indane, VP & Country Leader, Pall Corp.

2) Mr. Shreehas Tambe, COO,Biocon Biologics3) Dr. Vishal Warke, Director R&D, Himedia Labs4) Dr. Mahesh Bhalgat, COO, Syngene International Ltd.5) Dr. Umesh Shaligram, Director, Serum Institute of India

04:00 pm – 04:30 pm Talk Session Dr. Kavita Singh, Director, NBM, BIRAC 04:300 pm – 05:00 pm High Tea and Networking

Session D: Regulatory and Clinical innovations

Moderator: Dr. Narendra Chirmule, CEO, Symphony Tech/USP05:00 pm – 05:30 pm Talk Session Dr. Gillian Woollet, SVP, Avalere Health05:30 pm – 06:00 pm Talk Session Dr. Chandrashekhar Ranga, DDC, CDSCO

06:00 pm – 07:00 pm Panel Discussion 1) Dr. Ranjan Chakrabarti, VP, USP-India2) Dr. Sandeep Athalye, CMO, Biocon Biologics3) Dr. Gillian Woollet, SVP, Avalere Health4) Dr. Chandrashekhar Ranga, DDC, CDSCO5) Mr. Francis P. Crawley, Executive Director, GCPA, SIDCER

07:00 pm – 07:10 pm Conclusion and Way Forward

Ag

end

a

9 8

2020

BI PHARMA

J B ELAM

BIOCON BIOLOGICS

Biocon Biologics is a fully-integrated ‘pure play’ biosimilars organisation globally committed towards transforming patient lives through innovative and inclusive healthcare solutions. It is engaged in developing high-quality, affordable biosimilars aimed at expanding patient access to cutting-edge class of therapies across the world.

Biocon Biologics has one of the largest biosimilars portfolios, a wide global footprint, state-of-the-art manufacturing facilities, world-class R&D ecosystem, and high quality & compliance standards, enabling it to fulfi l unmet needs of patients across the globe. It has a product pipeline of 28 molecules, including 11 with Mylan, several with Sandoz, and is developing many independently. The Company’s therapeutic basket includes molecules for diabetes, oncology, immunology, dermatology, ophthalmology, neurology,

rheumatology and infl ammatory diseases. So far, the company has commercialized fi ve biosimilars: Trastuzumab, Pegfilgrastim, Bevacizumab, rh-Insulin and Insulin Glargine, in several markets worldwide. The Company has commercialized three of its biosimilars in the developed markets like EU, U.S., Japan and Australia. It is a leading global insulins player with over 15 years of experience in addressing the needs of patients with diabetes, having provided over 2 billion doses of human insulin worldwide, thus far.

With the scientifi c capabilities, scale of manufacturing, large product pipeline, strong talent pool and expertise in developing and commercialising biologics, the company aims to serve 5 million patients through its biosimilars and reach USD 1 billion revenue mark in FY22.

GOLD SPONSOR AND EXHIBITOR

9 8

2020

BI PHARMA

J B ELAM

SYNGENE INTERNATIONAL LTD.

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation focused global discovery, development and manufacturing organisation providing integrated scientifi c services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4000- strong team of scientists who work with clients from around the world to solve their scientifi c problems, improve R&D productivity, speedup time to market and lower the cost of innovation.

Contact: Ankush MalikEvent Marketing HeadEmail: ankush.Malik@syngeneintl.comWebsite: www.syngeneintl.com

BRONZE SPONSOR AND EXHIBITOR

11 10

2020

BI PHARMA

J B ELAM

PALL CORPORATION, PALL INDIA PVT. LTD.

Pall Biotech offers a blend of innovative traditional, single-use and continuous processing technologies and services to create scalable bioprocessing solutions that are fl exible to each type of manufacturer’s process. From concept through to design, validation and production, our team leverages best-in class technologies with industry-leading support for all bioprocessing applications. Whether that means fast-tracking a new drug, helping to ensure regulatory compliance, or making existing processes easier, faster and better, we are ready to fulfi l your unique needs.

In arena of Gene Therapy, Pall Biotech can provide fully integrated bioprocessing solutions, from discovery through to commercialization; from upstream through to fi nal fi lling; from initial design through to implementation.With a range of solutions covering multiple virus types, and with production in either adherent or suspension processes, our

extensive single-use portfolio can offer you the complete solution you need.

Want to learn more about how Pall Biotech can enhance your bioprocesses from start to fi nish?

Contact: Pavithra RamanarayananRegional Marketing Manager – South AsiaMobile: +91-9513715770Email: pavithra_ramanarayanan@pall.comWebsite: www.pall.com/biotech

BRONZE SPONSOR AND EXHIBITOR

11 10

2020

BI PHARMA

J B ELAM

BECKMAN COULTER LIFE SCIENCES

Beckman Coulter Life Sciences develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. For more than 80 years, our products have been making a difference in people’s lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.

Contact: Dr. Niraj KhuranaEmail: NKHURANA@beckman.comMobile : +91 85888 28264Website: www.beckman.com

BRONZE SPONSOR AND EXHIBITORBRONZE SPONSOR AND EXHIBITOR

13 12

2020

BI PHARMA

J B ELAM

SERUM INSTITUTE OF INDIA PVT. LTD.

Serum Institute of India Pvt. Ltd. is now the world’s largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world. Serum Institute of India is ranked as India’s No. 1 biotechnology company, manufacturing highly specialized life saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties. Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving

immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-suffi cient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines. The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Combination vaccine etc., so that not only Indian’s, but the entire under-privileged children of the world are protected from birth onwards.

Contact:Tel: +91-20-26993900Website: www.seruminstitute.com

BRONZE SPONSOR AND EXHIBITOR

13 12

2020

BI PHARMA

J B ELAM

USP

At USP, everything we do is in service of our mission to help protect and improve the health of people around the world. From the standards we create to the partnerships we foster, we continually work to build and reinforce a foundation that draws us closer to a world where everyone can be confi dent of quality in health and healthcare.

Our MissionTo improve global health through public standards and related programs that help ensure the quality, safety, and benefi t of medicines and foods.

Our VisionUSP envisions a world in which all have access to high quality, safe, and benefi cial medicines and foods. USP approaches this

vision with a sense of urgency and purpose, strengthened by its cadre of dedicated volunteers, members, and staff, and by working collaboratively with key stakeholders across the globe.

Our ImpactAs the world gets smaller and more connected, quality issues affect everyone. Diseases travel. Drug resistance grows. Fake medicines kill. The foundation of quality we’re building helps address these and other global health issues. Whether decreasing the prevalence of substandard and poor-quality medicines or helping to curb antimicrobial resistance, we’re there working to protect the health of people all over the world.

Contact:Website: www.usp.org

PARTNERSHIP

15 14

2020

BI PHARMA

J B ELAM

AGILENT TECHNOLOGIES INDIA PVT. LTD.

Agilent Technologies Inc. (NYSE: A) is world’s premier measurement company and a technology leader in the fi eld of Life sciences and Chemical analysis. Over the years Agilent has developed innovative analytical solutions for laboratory-dependent organizations in form of UHPLC’s, HPLC’s, GC’s, Columns and Chemistry products, Mass spectrometry (GCMS, LCMS, CEMS), Lab Automation Solutions, PCR/qPCR, Microarrays, Molecular Spectroscopy (FTIR, UV-VIS/NIR, Fluorescence Spectrophotometers), Atomic Spectroscopy (AAS/GFAAS, MP-AES, ICPOES/ICPMS) Laboratory informatics solutions, and comprehensive service programs to

enable scientists, manufacturers, researchers and regulatory agencies working in the fi eld of Pharmaceutical, Chemical, Food Testing, Environmental, Forensics, Genomics, Clinical and Contract Research & Academia to deliver their work more effectively and effi ciently.

Contact:Email: india-lsca_marketing@agilent.com Website: www.agilent.com

COLLABORATOR AND EXHIBITOR

15 14

2020

BI PHARMA

J B ELAM

SHIMADZU ANALYTICAL (INDIA) PVT. LTD.

Shimadzu Corporation, Japan founded in 1875 and having a history of more than 140 years, is one of the leading Manufacturers & suppliers of Analytical, scientifi c & testing instruments such as Chromatography, Mass-Spectrometry, Spectroscopy, Testing instruments, Environmental monitoring instruments.

Shimadzu Analytical (India) Pvt Ltd, a wholly owned subsidiary of Shimadzu Corporation, Japan, offers an extensive range of instruments, value added services & customer support. Shimadzu has been serving the Indian scientifi c community since many decades now, through its well established network of distributors namely Toshvin Analytical, Spinco Biotech, Swan Environmental, Saksham Analytical, Amkette Analytics & Perfomax Analytical for various product ranges. The Customer

Support Centres (CSC) in India (Mumbai & Delhi) were established in 2006 to reaffi rm the commitment towards our valued customers. It is a state-of-art facility with a wide range of analytical instruments and the key objective of providing application support & continuous technical training for analytical scientists to offer the best possible solutions to face the challenges faced by the analysts.

Contact: Ms. Amy ThakkerEmail: info@shimadzu.inPhone: +91 22 29204741Website: www.shimadzu.in

COLLABORATOR AND EXHIBITOR COLLABORATOR AND EXHIBITOR

17 16

2020

BI PHARMA

J B ELAM

MALVERN PANALYTICAL

Malvern Panalytical technologies are used by scientists and engineers in a wide range of industries and organizations to solve the challenges associated with maximizing productivity, developing better quality products and getting them to market faster. Our focus is on creating innovative, customer-focused solutions and services to enhance effi ciency and deliver tangible economic impact through chemical, physical and structural analysis of materials.

EPPENDORF

Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid handling, sample handling, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplifi cation equipment as well as ultra-low temperature freezers, fermenters, bioreactors, CO2 incubators, shakers, cell manipulation systems and consumables. Eppendorf products are broadly used in from the pharmaceutical, biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and at industrial laboratories. Since 1945, Eppendorf has more than 3,100 employees worldwide and it has subsidiaries in 26 countries.

EXHIBITOR EXHIBITOR

17 16

2020

BI PHARMA

J B ELAM

BIO-TECHNE

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purifi ed proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workfl ow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. Bio-Techne generated approximately $714 million in net sales in fi scal 2019 and has over 2,200 employees worldwide.

PERKINELMER (INDIA) PVT. LTD.

With a mission focused on innovating for a healthier world, PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges in science and health by offering unique instrument, informatics and service solutions for advanced testing and analysis. We deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. PerkinElmer established direct operations in India in 2004 and currently has more than 10,000 customers and over 550 employees in India. Globally, its dedicated team includes 13,000 employees across 180 countries.

EXHIBITOR EXHIBITOR

19 18

2020

BI PHARMA

J B ELAM

3M

The 3M Company, formerly known as the Minnesota Mining and Manufacturing Company, is an American multinational conglomerate corporation operating in the fi elds of industry, worker safety, health care, and consumer goods. The company produces over 60,000 products under several world-renowned brands. It is based in Maplewood, Minnesota, a suburb of St. Paul. 3M made $32.8 billion in total sales in 2018 and ranks number 95 in the Fortune 500 list of the largest United States corporations by total revenue. As of 2018, the company has approximately 93,500 employees, and has operations in more than 70 countries.

PHENOMENEX

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purifi cation challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. Phenomenex Inc. is now proud to be a part of Danaher Corporation as a piece of their Life Sciences group.

EXHIBITOR EXHIBITOR

19 18

2020

BI PHARMA

J B ELAM

COLE PARMER AND CHEMTEK

Since 1955, Cole-Parmer has been a leading global source of laboratory and industrial fl uid handling products, instrumentation, equipment, and supplies. We are proven experts in the fi elds of temperature measurement and control, electrochemistry, and fl uid handling. Our products are sold throughout the world through company-owned customer channel outlets and a strong network of international dealers. Cole-Parmer is renowned for offering exceptional service and technical support. Customers also rely on our team of trained and experienced application specialists for help in selecting the right product for their application, troubleshooting existing equipment, and solving regulatory compliance issues. It all adds up to a promise Cole-Parmer works to fulfi ll every day: delivering solutions you trust.

ALLIED SCIENTIFIC PRODUCTS

Allied Scientifi c Products was initiated as a company dealing with Consumables in 1991. It has made great strides and has shown a persistent increase in sales over the years and gradually become a company to cater both the sector for Consumables & Instruments Due to expansion of customer base we felt it was necessary to fl oat another company so our service to the customers remains at the highest level.We are not a market driven company but a customer driven one, so we choose the goods looking at the user.

EXHIBITOR EXHIBITOR

20

2020

BI PHARMA

J B ELAM

Supported by

BI PHARMA

J B ELAM

Institute of Chemical TechnologyNathalal Parekh Marg, Near Khalsa College, Matunga, Mumbai – 400 019, Maharashtra, IndiaTel: +91-22-3361 1111/ 2222

www.ictmumbai.edu.in